{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:36:25Z","timestamp":1761154585490},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.jacc.2003.09.059","type":"journal-article","created":{"date-parts":[[2004,3,12]],"date-time":"2004-03-12T10:20:40Z","timestamp":1079086840000},"page":"972-978","source":"Crossref","is-referenced-by-count":34,"title":["Aspirin dose and six-month outcome after an acute coronary syndrome"],"prefix":"10.1016","volume":"43","author":[{"given":"Martin J","family":"Quinn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert D","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M","family":"Califf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Kandzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J","family":"Topol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2003.09.059_BIB1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2003.09.059_BIB2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.102.10.1193","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.09.059_BIB3","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1053\/euhj.2000.2301","article-title":"Management of acute coronary syndromes","volume":"21","author":"Bertrand","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2003.09.059_BIB4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1993.tb05689.x","article-title":"The gastrointestinal toxicity of aspirin","volume":"35","author":"Roderick","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2003.09.059_BIB5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB6","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.09.059_BIB7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.296.6618.316","article-title":"United Kingdom transient ischemic attack (UK-TIA) aspirin trial","volume":"296","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.jacc.2003.09.059_BIB8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF00212985","article-title":"Controlled trial of high- versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease","volume":"72","author":"Ranke","year":"1994","journal-title":"Clin Invest"},{"key":"10.1016\/j.jacc.2003.09.059_BIB9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9149(97)89171-0","article-title":"Randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators","volume":"77","author":"O'Connor","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2003.09.059_BIB10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.CIR.96.4.1109","article-title":"Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina","volume":"96","author":"Cipollone","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.09.059_BIB12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0038-1645038","article-title":"Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina","volume":"63","author":"Vejar","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2003.09.059_BIB13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.09.059_BIB14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2003.09.059_BIB15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI110814","article-title":"Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man","volume":"71","author":"FitzGerald","year":"1983","journal-title":"J Clin Invest"},{"issue":"Suppl A","key":"10.1016\/j.jacc.2003.09.059_BIB16","first-page":"1A","article-title":"Pharmacogenomics","volume":"37","author":"Cooke","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2003.09.059_BIB17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199609123351103","article-title":"A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.09.059_BIB20","first-page":"349","article-title":"Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected myocardial infarction","volume":"ii","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.09.059_BIB21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","article-title":"Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina","volume":"88","author":"Theroux","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.09.059_BIB23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)01180-X","article-title":"Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.09.059_BIB25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc0502.103329","article-title":"Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction","volume":"105","author":"Fiore","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.09.059_BIB26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9149(90)91155-Y","article-title":"Usefulness of antithrombotic therapy in resting angina pectoris or non\u2013Q-wave myocardial infarction in preventing death and myocardial infarction","volume":"66","author":"Cohen","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2003.09.059_BIB27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0002-9149(02)02566-3","article-title":"Seeking the optimal aspirin dose in acute coronary syndromes","volume":"90","author":"Kong","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2003.09.059_BIB28","first-page":"232","article-title":"Inhibition of prostaglandin biosynthesis as a mechanism of action of aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2003.09.059_BIB29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patrignani","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2003.09.059_BIB30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.09.059_BIB31","first-page":"II721","article-title":"The risk of bleeding complications with antiplatelet agents","volume":"106","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.09.059_BIB32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.37.4.509","article-title":"Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin\u2014analysis of gastrointestinal bleeding during the UK-TIA trial","volume":"37","author":"Slattery","year":"1995","journal-title":"Gut"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T16:17:19Z","timestamp":1585671439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0735109704000178"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2003.09.059","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}